ECHQF (Echo IQ) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ECHQF Echo IQ Ltd ECHQF
13 GF Score
Price $1.25
GF Value $0.02
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Echo IQ 5-Year Yield-on-Cost %?

Echo IQ ECHQF 13 5-Year Yield-on-Cost % is 0.00 as of Jul. 25, 2026. GuruFocus rates ECHQF with a GF Score™ of 13/100 and a GF Value™ of $0.02 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 277 Healthcare Providers & Services companies, Echo IQ ranks worse than 361010.47% on this metric.

Echo IQ's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for Echo IQ's 5-Year Yield-on-Cost % or its related term are showing as below:



ECHQF's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.9
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Echo IQ  (OTCPK:ECHQF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Echo IQ 5-Year Yield-on-Cost % Related Terms


ECHQF vs VEEV, BTSG, TEM: 5-Year Yield-on-Cost % Comparison

For the Health Information Services subindustry, Echo IQ's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Echo IQ 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Echo IQ's 5-Year Yield-on-Cost % falls into.


ECHQF
13GF Score
Echo IQ Ltd ECHQF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Echo IQ 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Echo IQ is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Echo IQ (ECHQF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Echo IQ and its competitors. According to the industry distribution chart, Echo IQ ranks #999999 out of 277 companies in the Healthcare Providers & Services industry.
Is Echo IQ's 5-Year Yield-on-Cost % too high?
Echo IQ's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Echo IQ ranks #999999 out of 277 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Echo IQ has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's 5-Year Yield-on-Cost % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Echo IQ ranks #999999 out of 277 companies for 5-Year Yield-on-Cost %. This places Echo IQ in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Echo IQ and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Echo IQ's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Based on GuruFocus' analysis, Echo IQ (ECHQF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $1.25 — trading 6150% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Echo IQ's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Echo IQ (ECHQF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Echo IQ (ECHQF) Overvalued in 2026?

Based on GuruFocus' analysis, Echo IQ stock appears to be overvalued. The current stock price of $1.25 is trading 6150% above its estimated GF Value™ of $0.02. GuruFocus considers Echo IQ to be Significantly Overvalued.

Key valuation signals for ECHQF:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $0.02 vs. price of $1.25 (6150% above fair value)
  • GF Score™: 13/100 with 1 warning sign

No single metric tells the full story. See the ECHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Echo IQ Business Description

Other Exchanges PL4:GermanyEIQ:Australia
Address 264 Stirling Highway, U5, Claremont, Perth, WA, AUS, 6010
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
13GF Score

Get the complete analysis for ECHQF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25
Price
$0.02
GF Value